Coronavirus Rebound After Pfizer’s Paxlovid Oral Antiviral Drug
Eli Lilly Invest $2.1B in Indiana Pharmaceutical Manufacturing
FDA Approves First Drug for Chronic Disease Eosinophilic Esophagitis
Hospital Contrast Dye Shortage Results in Rationed Medical Imaging Care
Pfizer Acquires Biohaven Pharmaceutical for $11.6 Billion in Cash
FDA Issues Guidance for Dietary Supplement Marketplace
FDA Amends EUA For Pfizer-BioNTech’s COVID-19 Vaccine Booster
Prescription Drug Manufacturer Pre-Rebate Costs Skyrocket
FDA Lifts Clinical Hold on Gilead’s HIV Treatment, Lenacapavir
FDA Approves Eli Lilly and Company’s Type 2 Diabetes Injectable
Bristol Myers Squibb’s Drug Effective in Plaque Psoriasis Patients
Roche, Global Fund to Build Diagnostic Capacity of HIV, Tuberculosis
J&J Appoints Thibaut Mongon CEO of New Consumer Health Company
Janssen Pharmaceuticals Terminates Collaboration in Hepatitis B, HPV
Novo Nordisk, Flagship to Develop Rare Disease Treatments
FDA Limits Use of Johnson & Johnson COVID-19 Vaccine
Real-World Evidence Shows Pfizer’s Ibrance Improves Breast Cancer
Pfizer’s COVID-19 Treatment Reduces Disease by 37% Post-Exposure
Bristol Myers Ends Clinical Program for Combination Drug Therapy
Novartis’ Antibody Boosts Survival for Squamous Cell Carcinoma
Gilead, Dragonfly to Advance Immunotherapies in Oncology
Eli Lilly’s Obesity Drug Elicits 22.5% of Weight Loss in Adults
Roche’s Drug Improves Infants with Type 1 Spinal Muscular Atrophy
FDA Approves AstraZeneca’s Drug for Generalized Myasthenia Gravis
AstraZeneca to Open Drug Research, Development Site in MA
Dr. Vishal Sikka to Join GSK as Non-Executive Director
FDA Expands Approval of COVID-19 Treatment, Remdesivir
FDA Accepts AstraZeneca BLA for Hepatocellular Carcinoma Antibody
Pfizer Reports Positive Phase 2 Data for Lyme Disease Vaccine
Sandoz Launches Generic Drug Combination for Ocular Hypertension
J&J Launches Satellite Center to Tackle Antimicrobial Resistance